Article summary
The Medicines and Healthcare products Regulatory Agency has updated guidance on exporting active substances for human use manufactured in Great Britain for use in the EEA and Northern Ireland relating to the written confirmations for export required for third country export to the EEA under Article 46b(2)(b) of Directive 2001/83/EC.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial